Unaltered IL-2 encapsulated in acoustically active lipid microspheres for systemic but targeted microdose delivery to tumor microenvironment.

被引：0
|
作者：
Larsen, Clayton
Keltner, Llew
Redmond, William L.
Li, Rhodemann
机构：
[1] Vesselon Inc, Norwalk, CT USA
[2] EPISTAT, Portland, OR USA
[3] Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e14535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14535
引用
收藏
页数：3
相关论文
共 9 条
  • [1] Shift from systemic to site-specific memory by tumor-targeted IL-2
    Schrama, D
    Rong, XA
    Eggert, AO
    Andersen, MH
    Pedersen, LO
    Kämpgen, E
    Schumacher, TN
    Reisfeld, RR
    Becker, JC
    JOURNAL OF IMMUNOLOGY, 2004, 172 (10): : 5843 - 5850
  • [2] Tumor-Targeted Delivery of IL-2 by Fusing with a pH Low Insertion Peptide for Antitumor Immunotherapy
    Chu, Tianjiao
    Cao, Bowei
    Wang, Peina
    Li, Bozhao
    Ren, Jinna
    Nie, Guangjun
    Wei, Jingyan
    Li, Suping
    BIOCONJUGATE CHEMISTRY, 2023, 34 (10) : 1894 - 1901
  • [3] Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy
    Kim, Jun
    Kang, Seounghun
    Kim, Kyoung Won
    Heo, Myeong-Gang
    Park, Dae-In
    Lee, Joon-Hyung
    Lim, Nam Ju
    Min, Dal-Hee
    Won, Cheolhee
    Biomaterials, 2022, 280
  • [4] Nanoparticle delivery of recombinant IL-2 (BALLkine-2) achieves durable tumor control with less systemic adverse effects in cancer immunotherapy
    Kim, Jun
    Kang, Seounghun
    Kim, Kyoung Won
    Heo, Myeong-Gang
    Park, Dae-In
    Lee, Joon-Hyung
    Lim, Nam Ju
    Min, Dal-Hee
    Won, Cheolhee
    BIOMATERIALS, 2022, 280
  • [5] An HSV-1-based vector for local delivery of IL-12 and IL-2 reshapes the immune landscape leading to tumor clearance and systemic immune surveillance
    Previte, Dana M.
    Parry, Trevor J.
    Krishnan, Suma M.
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
    Kang, Tae Heung
    Mao, Chih-Ping
    He, Liangmei
    Tsai, Ya-Chea
    Liu, Katherine
    La, Victor
    Wu, T. -C.
    Hung, Chien-Fu
    PLOS ONE, 2012, 7 (04):
  • [7] Intratumoral delivery of TransCon™ TLR7/8 Agonist provides potent anti-tumor activity as a monotherapy and in combination with IL-2 while minimizing systemic cytokine induction
    Zuniga, Luis
    Lessmann, Torben
    Holten-Andersen, Lars
    Bisek, Nicola
    Zettler, Joachim
    Stark, Sebastian
    Faltinger, Frank
    Kracker, Oliver
    Weisbrod, Samuel
    Mueller, Robin
    Voigt, Tobias
    Bigott, Kornelia
    Tabrizifard, Mohammad
    Breinholt, Vibeke
    Sprogoe, Kennett
    Punnonen, Juha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] Intratumoral delivery of liposome-anchored anti-CD137 and IL-2 induces highly potent local and systemic anti-tumor immunity while minimizing toxic inflammatory side effects
    Kwong, Brandon
    Liu, Haipeng
    Irvine, Darrell
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [9] Regression of established autochthonous mammary tumors and induction of systemic anti-tumor T- and B-cell immunity in HER-2/NEU transgenic mice after treatment with IL-12 and GM-CSF-encapsulated microspheres
    Nair, ER
    Jong, YS
    Egilmez, NK
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S37 - S37
1